Skip to content

R0041/2026-04-01/Q002/S02

Research R0041 — Enterprise Sycophancy
Run 2026-04-01
Query Q002
Search S02

WebSearch — FDA AI healthcare clinical decision support sycophancy

Summary

Field Value
Source/Database WebSearch
Query terms FDA AI healthcare clinical decision support disagreement safety sycophantic
Filters None
Results returned 10
Results selected 3
Results rejected 7

Selected Results

Result Title URL Rationale
S02-R01 The illusion of safety: A report to the FDA on AI healthcare https://pmc.ncbi.nlm.nih.gov/articles/PMC12140231/ PMC paper on FDA AI oversight gaps including sycophancy
S02-R02 FDA medical device loophole could cause patient harm https://www.healthcareitnews.com/news/fda-medical-device-loophole-could-cause-patient-harm-study-warns Reporting on LLM-specific risks in clinical settings
S02-R03 AI in Health Care and the FDA's Blindspot https://ldi.upenn.edu/our-work/research-updates/ai-in-health-care-and-the-fdas-blind-spot/ Penn analysis of FDA regulatory gaps

Rejected Results

Result Title URL Rationale
S02-R04 FDA Oversight of Health AI Tools https://bipartisanpolicy.org/issue-brief/fda-oversight-understanding-the-regulation-of-health-ai-tools/ General oversight, not sycophancy-specific
S02-R05 AHA Letter to FDA on AI-enabled Medical Devices https://www.aha.org/lettercomment/2025-12-01-aha-letter-fda-ai-enabled-medical-devices Advocacy letter, not sycophancy-focused
S02-R06 New FDA Policies and AI in Medicine https://jamanetwork.com/journals/jama-health-forum/fullarticle/2830189 Policy analysis, generic AI concerns
S02-R07 FDA regulatory framework for AI in trials https://www.hoganlovells.com/en/publications/fdas-evolving-regulatory-framework-for-ai-use-in-drug-device-clinical-trials-and-research Clinical trials focus, not clinical decision support
S02-R08 FDA New Guidance Signals https://oncodaily.com/industry/fda-8 Oncology-specific, not sycophancy
S02-R09 A report to the FDA (PDF) https://journals.plos.org/digitalhealth/article/file?id=10.1371/journal.pdig.0000866&type=printable PDF version of R01
S02-R10 Strengthening AI in healthcare delivery https://pmc.ncbi.nlm.nih.gov/articles/PMC11187419/ General AI governance in healthcare

Notes

Healthcare searches found that sycophancy is being discussed as a patient safety risk by researchers, but the FDA has not issued guidance specifically addressing sycophantic LLM behavior.